NCT00450814: A trial that was reported late by Mayo Clinic
This trial has reported, although it was 33 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT00450814 |
|---|---|
| Title | Phase I/II Trial of Systemic Administration of Edmonston Strain of Measles Virus, Genetically Engineered to Express NIS, With or Without Cyclophosphamide, in Patients With Recurrent or Refractory Multiple Myeloma |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Nov. 30, 2006 |
| Completion date | July 10, 2018 |
| Required reporting date | July 10, 2019, midnight |
| Actual reporting date | Aug. 12, 2019 |
| Date last checked at ClinicalTrials.gov | June 9, 2026 |
| Days late | 33 |